Singapore is pioneering an innovative approach to Covid-19 research through human challenge studies, where volunteers are deliberately infected with the virus in controlled settings. This approach contrasts with traditional methods where infections occur naturally, allowing researchers to obtain
Agilent Technologies has made a significant leap forward with the receipt of EU In Vitro Diagnostic Regulation (IVDR) certification for its PD-L1 IHC 28-8 pharmDx kit as a companion diagnostic for non-small cell lung cancer (NSCLC) and melanoma. This certification broadens the indications for the
Blood tests have come a long way since the 19th century, evolving into essential tools for diagnosing and monitoring various health conditions, including cancer. In breast cancer care, blood tests play a crucial role, providing valuable insights that complement other diagnostic methods. The Role of
Geneoscopy, a healthcare company, has announced the commercial launch of Colosense, a groundbreaking at-home colorectal cancer screening test. This innovative, noninvasive test comes on the heels of an impressive $105 million funding round and FDA approval, positioning Colosense as a major player
Personalized medicine through IVD (In Vitro Diagnostics) represents a transformative shift in healthcare, focusing on tailored medical treatment based on individual patient profiles. This innovative approach is reshaping how diseases are diagnosed, monitored, and treated, promising improved
The FDA's recent approval of Illumina's TruSight Oncology (TSO) Comprehensive, an in vitro diagnostic (IVD) biomarker test kit, represents a notable milestone in cancer treatment. This approval paves the way for more personalized and precise therapy options for cancer patients. By
1 2
